Howard Elmo Gill Iii, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-9685 Fax: 210-539-9343 |
Dr. Jason Leon Reed, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-2888 Fax: 210-539-9343 |
Dr. Gabrielle F Daniel, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-5586 |
Sean Robert Fletcher, M.D. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-2888 |
Dr. Alan W Young, D.O Physical Medicine & Rehabilitation - Spinal Cord Injury Medicine Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-696-5858 Fax: 210-558-4464 |
Dr. Andre C. L. Liem, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: Bamc, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234 Phone: 202-868-3847 |
News Archive
XBiotech, a privately held biotechnology company, announced positive interim analysis results today from a Phase II study using a True Human monoclonal antibody (MABp1) in patients with type 2 diabetes. Results from this study continue to reinforce the role of IL-1α as a master regulator of chronic inflammation in multiple disease states, and the therapeutic benefits of neutralizing antibodies produced from the XBiotech platform.
For years, fiber intake among the global population has been extremely low, setting the stage for potentially serious, long-term public health implications. New research commissioned by Tate & Lyle and presented at the 2012 Experimental Biology conference in San Diego adds to the body of emerging research on fibers, including additional support for the role of soluble corn fiber in bone health.
A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. "Genomic studies in other cancer types have resulted in new drug targets and strategies to classify patients into clinically meaningful subgroups that improve treatment decisions," said senior study author Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program at MSKCC and a HHMI investigator. "This first -ever database of its type brings us one step closer to achieving that goal in prostate cancer."
Sunquest Information Systems, Inc., a privately held market leader in laboratory and diagnostic information systems, today announced that the Fiscal Year 2009 ending May 31 was its most successful in the 30 year history of the company. This success is continuing into the new fiscal year, as sales orders for first quarter FY 2010, ending August 31, 2009 increased more than 30 percent compared to the same quarter a year ago.
New evidence-based guidelines from the American College of Chest Physicians (ACCP) and the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) recommend a comprehensive pulmonary rehabilitation program for patients with chronic obstructive pulmonary disease (COPD), citing that pulmonary rehabilitation can help improve a patient's exercise tolerance, dyspnea, and health-related quality of life, as well as decrease hospital stay and health-care utilization.
› Verified 5 days ago